Article Details

Venture capital pours more money into RNA medicines with the launch of Replicate ...

Retrieved on: 2021-09-08 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Venture capital pours more money into RNA medicines with the launch of Replicate .... View article details on hiswai:

Excerpt

Replicate's approach is different from Moderna's and BioNTech's, which rely on so-called messenger RNA. Instead of just providing instructions on how to make ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up